Products 2446928-30-7

CAS 2446928-30-7 appears in our catalog under these names: BMS-986365/ 99.96% (existing batch purity), BMS–986365, BMS-986365 98%, CC-94676, BMS-986365, 99.92%. Offered by: TargetMol, GLPBio, Ambeed, Chemat, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 250mg, 1g.

BMS-986365/ 99.96% (existing batch purity)
TargetMol
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 1415.27
View product
BMS–986365
GLPBio
  • size: 1mg, 10mg, 25mg, 5mg
  • Variants: 5
from 1434.85
View product
BMS-986365 98%
Ambeed
  • size: 10mg, 25mg, 50mg, 100mg
  • Variants: 5
from 1121.31
View product
CC-94676
Chemat
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 6
from 299.60
View product
BMS-986365, 99.92%
MedChemExpress
  • size: 500 mg, 50 mg, 100 mg, 25 mg
  • Variants: 8
from 1053.44
View product
Structural formula: {0} (CAS {1})

2-[(2R)-4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]ethyl]-2-methylpiperazin-1-yl]-N-[3-[(2,6-dioxopiperidin-3-yl)amino]phenyl]acetamide (CAS 2446928-30-7) is a chemical compound with the molecular formula C41H45F3N8O5S and a molecular weight of 818.9 g/mol. IUPAC name: 2-[(2R)-4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]ethyl]-2-methylpiperazin-1-yl]-N-[3-[(2,6-dioxopiperidin-3-yl)amino]phenyl]acetamide. InChIKey: YUVGVJYLOFTILT-NHYGQJMQSA-N.

Identity
Molecular formulaC41H45F3N8O5S
Molecular weight818.9 g/mol
IUPAC name2-[(2R)-4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]ethyl]-2-methylpiperazin-1-yl]-N-[3-[(2,6-dioxopiperidin-3-yl)amino]phenyl]acetamide
InChIKeyYUVGVJYLOFTILT-NHYGQJMQSA-N
SMILESCCC1=C(C=CC(=C1)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F)OCCN4CCN([C@@H](C4)C)CC(=O)NC5=CC=CC(=C5)NC6CCC(=O)NC6=O

Computed by PubChem (NCBI)

Synonyms: Dezandrodeg, Dezandrodeg (USAN), orb2281155, YUVGVJYLOFTILT-NHYGQJMQSA-N
Related forms of this compound
2-[(2R)-4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-ethylphenoxy]ethyl]-2-methylpiperazin-1-yl]-N-[3-[[(3R)-2,6-dioxopiperidin-3-yl]amino]phenyl]acetamide C41H45F3N8O5S